Dr Pallavi Bradshaw, Medical Director at AXA Health insurance, has outlined the six early symptoms of breast cancer that ...

Punam Krishan says she has been diagnosed with breast cancer ...

Women younger than 50 accounted for about a quarter of all breast cancers diagnosed at a large community imaging practice in New York, with a substantial number in women under age 40, a retrospective ...

Brooke Nickel receives fellowship funding from the National Health and Medical Research Council (NHMRC). She is on the Executive Committee for Wiser Healthcare and the Scientific Committee of the ...

Simone Biles is opening up about her breast implant journey, revealing new details about the procedure she underwent last June. In a recent TikTok, the Olympic icon disclosed the size of the implants ...

She’s just been diagnosed with a rare condition called gigantomastia, a severe form of macromastia, which causes excess ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? In a recent Instagram post, one prominent New York City dermatologist exposed ...

Pure Fresh is one of the Mitchum 48-Hour Roll On 100ml deodorants affected. (Mitchum UK/Amazon) A group of women who say they were left with "permanent scarring" after using Mitchum roll-on deodorant ...

Women have a 12.9% — or about 1 in 8 — chance of contracting breast cancer during their lifetime, according to the National Cancer Institute. While breast cancer risk increases with age, a 2024 ...

The ACR recommends most women have yearly mammograms starting at age 40. Breast cancer awareness campaigns often focus on mammograms and self-exams. But there's another critical piece of the puzzle ...

Hashimoto’s rash refers to a rash or hives associated with Hashimoto’s thyroiditis, but it’s not an official or distinct diagnosis. Hashimoto’s thyroiditis is an autoimmune condition that occurs when ...

A Prescription Drug User Fee Act target date of May 18, 2026 has been set for the application. The sBLA submission was supported by data from the randomized, open-label, phase 3 DESTINY-Breast11 trial ...